All Episodes

February 21, 2024 53 mins
“We’re going to be helping hundreds of thousands of patients with our device and that’s probably more than a lifetime of patients I could see as a physician.” By the time Allisa Song started medical school at Mayo Clinic in 2018, she was already the founder of an active medical device startup company called Nanodropper. The idea came to her in 2017, when she happened to read an article titled: "Drug Companies Make Eyedrops Too Big, and You Pay for the Waste.” “It really felt like we were letting people down,” Song says. “We have these great medications that are vision saving, and we’re dangling it in front of people, saying that you have to pay this amount if you want to keep your vision.” The cost, the structure of benefits—it all felt “unfair,” Song says. But rather than go for the big industry-wide fix, she approached the wasted eye medicine problem with a harm reductionist mentality. “I was just trying to think about how can we develop a solution that we could put directly into the hands of patients.” That, for Song, was an eye drop bottle adapter with a smaller opening for less waste. The product, which sells for $19.99, is now available direct to consumer online and through thousands of medical clinics nationwide. Song talks about leveraging student startup competitions to fund the business, and juggling entrepreneurship with medical school. “Taking that first step in bringing your idea to life is a really powerful feeling.” Following our conversation with Song we go Back to the Classroom with Dan McLaughlin, senior executive fellow at the University of St. Thomas Opus College of Business, with a focus on health innovation. “One of the things I teach in my operations management class is how do you improve processes?” Often the best way to make a big impact is by addressing something small or seemingly mundane. Look for the opportunities, McLaughlin advises, in your daily routine.
Mark as Played

Advertise With Us

Popular Podcasts

Las Culturistas with Matt Rogers and Bowen Yang

Las Culturistas with Matt Rogers and Bowen Yang

Ding dong! Join your culture consultants, Matt Rogers and Bowen Yang, on an unforgettable journey into the beating heart of CULTURE. Alongside sizzling special guests, they GET INTO the hottest pop-culture moments of the day and the formative cultural experiences that turned them into Culturistas. Produced by the Big Money Players Network and iHeartRadio.

Crime Junkie

Crime Junkie

Does hearing about a true crime case always leave you scouring the internet for the truth behind the story? Dive into your next mystery with Crime Junkie. Every Monday, join your host Ashley Flowers as she unravels all the details of infamous and underreported true crime cases with her best friend Brit Prawat. From cold cases to missing persons and heroes in our community who seek justice, Crime Junkie is your destination for theories and stories you won’t hear anywhere else. Whether you're a seasoned true crime enthusiast or new to the genre, you'll find yourself on the edge of your seat awaiting a new episode every Monday. If you can never get enough true crime... Congratulations, you’ve found your people. Follow to join a community of Crime Junkies! Crime Junkie is presented by audiochuck Media Company.

The Brothers Ortiz

The Brothers Ortiz

The Brothers Ortiz is the story of two brothers–both successful, but in very different ways. Gabe Ortiz becomes a third-highest ranking officer in all of Texas while his younger brother Larry climbs the ranks in Puro Tango Blast, a notorious Texas Prison gang. Gabe doesn’t know all the details of his brother’s nefarious dealings, and he’s made a point not to ask, to protect their relationship. But when Larry is murdered during a home invasion in a rented beach house, Gabe has no choice but to look into what happened that night. To solve Larry’s murder, Gabe, and the whole Ortiz family, must ask each other tough questions.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.